Intravenous Contrast Agent Influence on Thoracic Computed Tomography Simulation Investigated Through A Heterogeneous Dose Calculation Method Using 5-Bulk Densities

Synthetic computed tomography generation for abdominal adaptive radiotherapy using low-field magnetic resonance imaging

Background and Purpose

Magnetic Resonance guided Radiotherapy (MRgRT) still needs the acquisition of Computed Tomography (CT) images and co-registration between CT and Magnetic Resonance Imaging (MRI). The generation of synthetic CT (sCT) images from the MR data can overcome this limitation. In this study we aim to propose a Deep Learning (DL) based approach for sCT image generation for abdominal Radiotherapy using low field MR images.

Materials and methods

CT and MR images were collected from 76 patients treated on abdominal sites. U-Net and conditional Generative Adversarial Network (cGAN) architectures were used to generate sCT images. Additionally, sCT images composed of only six bulk densities were generated with the aim of having a Simplified sCT.Radiotherapy plans calculated using the generated images were compared to the original plan in terms of gamma pass rate and Dose Volume Histogram (DVH) parameters.

Results

sCT images were generated in 2 s and 2.5 s with U-Net and cGAN architectures respectively.Gamma pass rates for 2%/2mm and 3%/3mm criteria were 91% and 95% respectively. Dose differences within 1% for DVH parameters on the target volume and organs at risk were obtained.

Conclusion

U-Net and cGAN architectures are able to generate abdominal sCT images fast and accurately from low field MRI.

Oral contrast agents lead to underestimation of dose calculation in volumetric-modulated arc therapy planning for pelvic irradiation

Supplemental Digital Content is available in the text

Background

The effects of oral contrast agents (OCAs) on dosimetry have not been studied in detail. Therefore, this study aimed to examine the influence of OCAs on dose calculation in volumetric-modulated arc therapy plans for rectal cancer.

Methods

From 2008 to 2016, computed tomography (CT) images were obtained from 33 rectal cancer patients administered OCA with or without intravenous contrast agent (ICA) and 14 patients who received no contrast agent. CT numbers of organs at risk were recorded and converted to electronic densities. Volumetric-modulated arc therapy plans were designed before and after the original densities were replaced with non-enhanced densities. Doses to the planned target volume (PTV) and organs at risk were compared between the plans.

Results

OCA significantly increased the mean and maximum densities of the bowels, while the effects of ICA on these parameters depended on the blood supply of the organs. With OCA, the actual doses for PTV were significantly higher than planned and doses to the bowel increased significantly although moderately. However, the increase in the volume receiving a high-range doses was substantial (the absolute change of intestine volume receiving ≥52 Gy: 1.46 [0.05−3.99, cubic centimeter range: −6.74 to 128.12], the absolute change of colon volume receiving ≥50 Gy: 0.34 [0.01−1.53 cc, range: −0.08 to 3.80 cc]. Dose changes due to ICA were insignificant. Pearson correlation showed that dose changes were significantly correlated with a high intestinal volume within or near the PTV (ρ > 0.5, P < 0.05) and with the density of enhanced intestine (ρ > 0.3, P < 0.05).

Conclusions

Contrast agents applied in simulation cause underestimation of doses in actual treatment. The overdose due to ICA was slight, while that due to OCA was moderate. The bowel volume receiving ≥50Gy was dramatically increased when OCA within the bowel was absent. Physicians should be aware of these issues if the original plan is barely within clinical tolerance or if a considerable volume of enhanced intestine is within or near the PTV.